Elvitegravir
- Catalog NO.:A25154
- CAS No. : 697761-98-1
- Molecular Formula:C23H23ClFNO5
- Molecular Weight: 447.88
Note*
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
1. Please click the to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Quality Control&SDS
Product Details
CAS Number | 697761-98-1 | Appearance | Normal |
Catalog Number | A25154 | MDL Number | MFCD11846134 |
Molecular Formula | C23H23ClFNO5 | Molecular Weight | 447.88 |
Boiling Point | Melting Point | ||
Flash Point | Density | ||
Synonyms | (S)-6-(3-chloro-2-fluorobenzyl)-1-(1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | ||
Storage Condition | Store in a tightly closed container,in a cool and dry place |
Safety
GHS Pictogram | |||
Signal Word | Warning | UN Number | |
Hazard Statements | H302;H315;H319;H335 | Class | |
Precautionary Statements | P261;P280;P301+P312;P302+P352;P305+P351+P338 | Packing Group |
Description
Elvitegravir (EVG, formerly GS-9137) is an integrase inhibitor used to treat HIV infection. The drug gained approval by the U.S. Food and Drug Administration on August 27, 2012 for use in adult patients starting HIV treatment for the first time as part of the fixed dose combination known as Stribild. According to the results of the phase II clinical trial, patients taking once-daily elvitegravir boosted by ritonavir had greater reductions in viral load after 24 weeks compared to individuals randomized to receive a ritonavir-boosted protease inhibitor. |